About this trial
The goal of this study is to determine if estradiol and progesterone are involved in appetite regulation and energy balance. The study aims to complete a 13 day randomized controlled trial (RCT) where oral supplementation of estradiol only, progesterone only, a combination of each, or a placebo in young males will be provided. During the supplementation period, participants will complete two in-lab sessions where they will complete an acute bout of high-intensity interval training or a period of seated rest (completed on separate days by each participant) and have blood samples and perceptions of appetite measured taken over the course of the in-lab sessions. At the end of each session participants will consume an ad-libitum meal and participants will also track free-living energy intake and wear a thigh-worn accelerometer to measure energy expenditure for three days (day before, day of, and day after) each in-lab session.
Eligibility criteria
Qualifiers
ages 18-30 years
deemed healthy using Canadian Society for Exercise Physiology Get Active Questionnaire (CSEP-GAQ)
non-smoking
Disqualifiers
failure to meet inclusion criteria
contraindications to exercise as indicated by the (CSEP-GAQ)
hypersensitivity or allergy to estradiol, progesterone, cellulose, or capsule components
having been diagnosed with any metabolic disease (ie. diabetes, metabolic syndrome) or current diagnosis of overweight/obesity (BMI > 30.0)
Trial design
Treatments tested in this trial
- Placebo Comparator
- Estradiol Only
- Progesterone Only
- Estradiol and Progesterone Combination